Synthetic D-amino Acid Peptide Inhibits Tumor Cell Motility on Laminin-5

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2006 Mar 16

PMID 16537560

Citations 22

Authors

Thomas C Sroka

Michael E Pennington

Anne E Cress

Affiliations

Soon will be listed here.

Abstract

Cell motility is partially dependent on interactions between the integrins and the extracellular matrix. Our previous studies have identified synthetic D-amino acid cell adhesion peptides using a combinatorial screening approach. In this study, we demonstrate that HYD1 (kikmviswkg) completely blocks random haptotactic migration and inhibits invasion of prostate carcinoma cells on laminin-5. This effect is adhesion independent and reversible. The inhibition of migration by HYD1 involves a dramatic remodeling of the actin cytoskeleton resulting in increased stress fiber formation and actin colocalization with cortactin at the cell membrane. HYD1 interacts with alpha6beta1 (not alpha6beta4) and alpha3beta1 integrins and surprisingly elevates laminin-5-dependent intracellular signals including focal adhesion kinase, mitogen-activated protein kinase kinase and extracellular signal-regulated kinase. HYD1 does not contain a previously characterized binding sequence for integrins. A scrambled derivative of HYD1, called HYDS (wiksmkivkg), does not interact with the alpha6 or alpha3 integrin subunits and is not biologically active. Taken together, these results indicate that HYD1 is a biologically active integrin-targeting peptide that reversibly inhibits tumor cell migration on laminin-5 and uncouples phosphotyrosine signaling from cytoskeletal-dependent migration.

Citing Articles

Biological implications of decoding the extracellular matrix of vulva cancer.

Islam M, Debnath K, Moniruzzaman R, Okuyama K, Islam S, Dongre H Oncol Rep. 2024; 53(2).

PMID: 39670289 PMC: 11652961. DOI: 10.3892/or.2024.8852.

Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo.

Marr K, Gard J, Harryman W, Keeswood E, Paxson A, Wolgemuth C Biophys J. 2023; 122(21):4194-4206.

PMID: 37766428 PMC: 10645557. DOI: 10.1016/j.bpj.2023.09.016.

Extracellular Vesicle ITGAM and ITGB2 Mediate Severe Acute Pancreatitis-Related Acute Lung Injury.

Hu Q, Zhang S, Yang Y, Li J, Kang H, Tang W ACS Nano. 2023; 17(8):7562-7575.

PMID: 37022097 PMC: 10134486. DOI: 10.1021/acsnano.2c12722.

Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β-hairpin-like scaffold, MTI-101.

Jain P, Badger D, Liang Y, Gebhard A, Santiago D, Murray P Pept Sci (Hoboken). 2022; 113(3):e24199.

PMID: 35859761 PMC: 9285608. DOI: 10.1002/pep2.24199.

Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas.

Meireles Da Costa N, Mendes F, Pontes B, Nasciutti L, Pinto L, Junior A Cancers (Basel). 2021; 13(8).

PMID: 33920762 PMC: 8071176. DOI: 10.3390/cancers13081890.

References

Gu J, Sumida Y, Sanzen N, Sekiguchi K . Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-CrkII-DOCK180 pathway. J Biol Chem. 2001; 276(29):27090-7. DOI: 10.1074/jbc.M102284200. View

Carey T, Laurikainen L, Ptok A, Reinke T, Linder K, Nair T . Culture conditions affect expression of the alpha 6 beta 4 integrin associated with aggressive behavior in head and neck cancer. Adv Exp Med Biol. 1992; 320:69-79. DOI: 10.1007/978-1-4615-3468-6_10. View

Sahai E, Marshall C . Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol. 2003; 5(8):711-9. DOI: 10.1038/ncb1019. View

Ponce M, Hibino S, Lebioda A, Mochizuki M, Nomizu M, Kleinman H . Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth. Cancer Res. 2003; 63(16):5060-4. View

Nakahara H, Mueller S, Nomizu M, Yamada Y, Yeh Y, Chen W . Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem. 1998; 273(1):9-12. DOI: 10.1074/jbc.273.1.9. View

Murayama O, Nishida H, Sekiguchi K . Novel peptide ligands for integrin alpha 6 beta 1 selected from a phage display library. J Biochem. 1996; 120(2):445-51. DOI: 10.1093/oxfordjournals.jbchem.a021431. View

Plopper G, Domanico S, Cirulli V, Kiosses W, Quaranta V . Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res Treat. 1999; 51(1):57-69. DOI: 10.1023/a:1006086218174. View

Fincham V, James M, Frame M, Winder S . Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 2000; 19(12):2911-23. PMC: 203361. DOI: 10.1093/emboj/19.12.2911. View

Skubitz A, Letourneau P, Wayner E, Furcht L . Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit. J Cell Biol. 1991; 115(4):1137-48. PMC: 2289936. DOI: 10.1083/jcb.115.4.1137. View

10.

Slack J, Adams R, Rovin J, Bissonette E, Stoker C, Parsons J . Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene. 2001; 20(10):1152-63. DOI: 10.1038/sj.onc.1204208. View

11.

Kariya Y, Miyazaki K . The basement membrane protein laminin-5 acts as a soluble cell motility factor. Exp Cell Res. 2004; 297(2):508-20. DOI: 10.1016/j.yexcr.2004.03.044. View

12.

Iwamoto Y, Robey F, Graf J, Sasaki M, Kleinman H, Yamada Y . YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science. 1987; 238(4830):1132-4. DOI: 10.1126/science.2961059. View

13.

Nomizu M, Kim W, Yamamura K, Utani A, Song S, Otaka A . Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem. 1995; 270(35):20583-90. DOI: 10.1074/jbc.270.35.20583. View

14.

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

15.

Pollard T, Borisy G . Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003; 112(4):453-65. DOI: 10.1016/s0092-8674(03)00120-x. View

16.

Calalb M, Polte T, Hanks S . Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol. 1995; 15(2):954-63. PMC: 231984. DOI: 10.1128/MCB.15.2.954. View

17.

Schmelz M, Cress A, Scott K, Burger F, Cui H, Sallam K . Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia. 2002; 4(3):243-54. PMC: 1531698. DOI: 10.1038/sj.neo.7900223. View

18.

Colognato H, Yurchenco P . Form and function: the laminin family of heterotrimers. Dev Dyn. 2000; 218(2):213-34. DOI: 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R. View

19.

Song S, Nomizu M, Yamada Y, Kleinman H . Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells. Int J Cancer. 1997; 71(3):436-41. DOI: 10.1002/(sici)1097-0215(19970502)71:3<436::aid-ijc22>3.0.co;2-c. View

20.

Vuori K, Ruoslahti E . Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem. 1995; 270(38):22259-62. DOI: 10.1074/jbc.270.38.22259. View